ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

Background and purpose Multiple sclerosis (MS) is a complex disease with new drugs becoming available in the past years. There is therefore a need for a reference tool compiling current data to aid professionals in treatment decisions. The objective was to develop an evidence‐based clinical practice...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of neurology Jg. 25; H. 2; S. 215 - 237
Hauptverfasser:	Montalban, X., Gold, R., Thompson, A. J., Otero‐Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S., Selmaj, K., Siva, A., Sorensen, P. S., Sormani, M. P., Thalheim, C., Wiendl, H., Zipp, F.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley & Sons, Inc 01.02.2018
Schlagworte:	Central nervous system Clinical medicine Decision making demyelinating diseases disease‐modifying treatment Drug therapy Drugs Europe Experimental allergic neuritis GRADE methodology guideline Health care Humans Medical personnel Multiple sclerosis Multiple Sclerosis - drug therapy neurological disorders Neurology Neurology - standards Pharmacology Practice Guidelines as Topic - standards Pregnancy Quality research methods Safety Societies, Medical - standards Europe research methods GRADE methodology multiple sclerosis guideline neurological disorders diseases demyelinating disease-modifying treatment
ISSN:	1351-5101, 1468-1331, 1468-1331
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!